arrow
M

Martina Goetsch

Pfizer AG
H指数:8
被引数:517

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program

Etrasimod作为溃疡性结肠炎一线先进疗法的有效性与安全性:ELEVATE UC临床计划中预设及事后分析亚组数据

2026-07-270
PRE
Impact of up to 3 years of continuous etrasimod treatment: Long-term efficacy results from the ELEVATE UC open-label extension

为期长达3年的连续依特拉西莫德治疗的影响:ELEVATE UC开放标签扩展研究中的长期疗效结果

2026-01-010
PRE
Long-term etrasimod efficacy in patients with Ulcerative Colitis stratified by prior biologic/JAKi experience: 2-year outcomes from ELEVATE UC OLE

溃疡性结肠炎患者中长效etrasimod的疗效分析:根据既往生物制剂/JAKi使用经验分层,ELEVATE UC OLE研究2年结果

2026-01-010
PRE
Body Mass Index Did Not Affect Efficacy and Safety of Etrasimod: A Post Hoc Analysis of the ELEVATE Ulcerative Colitis Clinical Program

体重指数未影响依特拉西莫德的有效性和安全性:ELEVATE UC 临床项目的事后分析

2025-11-011
PRE